Eps Summary of Evolva Holding SA

Evolva Holding SA's latest annual eps in 2023 was -14.04 CHF , down -38.6% from previous year.
Evolva Holding SA's latest quarterly eps in 2023 FY was N/A , down -38.6% from previous quarter.
Evolva Holding SA reported an annual eps of -10.13 CHF in 2022, up 13.57% from previous year.
Evolva Holding SA reported an annual eps of -11.72 CHF in 2021, down -23.5% from previous year.
Evolva Holding SA reported a quarterly eps of -1.50 CHF for 2023 Q4, down 0.0% from previous quarter.
Evolva Holding SA reported a quarterly eps of -1.50 CHF for 2023 Q3, up 91.48% from previous quarter.

Annual Eps Chart of Evolva Holding SA (2023 - 2012)

Historical Annual Eps of Evolva Holding SA (2023 - 2012)

Year	Eps	Eps Growth
2023	-14.04 CHF	-38.6%
2022	-10.13 CHF	13.57%
2021	-11.72 CHF	-23.5%
2020	-9.49 CHF	-35.19%
2019	-7.02 CHF	25.95%
2018	-9.48 CHF	53.09%
2017	-20.21 CHF	-6.82%
2016	-18.92 CHF	0.05%
2015	-18.93 CHF	2.47%
2014	-19.41 CHF	-12.26%
2013	-17.29 CHF	25.12%
2012	-23.09 CHF	0.0%

Year	Eps	Eps Growth
2023 Q2	-17.60 CHF	-100.0%
2023 Q4	-1.50 CHF	0.0%
2023 Q3	-1.50 CHF	91.48%
2023 FY	- CHF	-38.6%
2023 Q1	-8.80 CHF	-170.77%
2022 FY	- CHF	13.57%
2022 Q3	-1.54 CHF	76.49%
2022 Q4	-3.25 CHF	-111.04%
2022 Q2	-6.55 CHF	-87.14%
2022 Q1	-3.50 CHF	16.86%
2021 Q1	-3.75 CHF	27.18%
2021 Q2	-7.52 CHF	-100.53%
2021 FY	- CHF	-23.5%
2021 Q3	-2.17 CHF	71.14%
2021 Q4	-4.21 CHF	-94.01%
2020 Q2	-4.34 CHF	-73.6%
2020 Q4	-5.15 CHF	-125.88%
2020 Q1	-2.50 CHF	31.51%
2020 Q3	-2.28 CHF	47.47%
2020 FY	- CHF	-35.19%
2019 Q4	-3.65 CHF	-31.29%
2019 Q3	-2.78 CHF	16.52%
2019 Q2	-3.33 CHF	-166.4%
2019 Q1	-1.25 CHF	44.44%
2019 FY	- CHF	25.95%
2018 Q2	-2.50 CHF	0.0%
2018 Q3	-2.25 CHF	10.0%
2018 FY	- CHF	53.09%
2018 Q4	-2.25 CHF	0.0%
2018 Q1	-2.50 CHF	40.19%
2017 Q3	-4.18 CHF	33.12%
2017 Q4	-4.18 CHF	0.0%
2017 FY	- CHF	-6.82%
2017 Q2	-6.25 CHF	0.0%
2017 Q1	-6.25 CHF	-22.55%
2016 Q3	-5.10 CHF	18.4%
2016 FY	- CHF	0.05%
2016 Q1	-6.25 CHF	-23.03%
2016 Q2	-6.25 CHF	0.0%
2016 Q4	-5.10 CHF	0.0%
2015 Q1	-6.25 CHF	-32.42%
2015 Q4	-5.08 CHF	0.0%
2015 Q3	-5.08 CHF	18.72%
2015 FY	- CHF	2.47%
2015 Q2	-6.25 CHF	0.0%
2014 FY	- CHF	-12.26%
2014 Q3	-4.72 CHF	5.6%
2014 Q1	-5.00 CHF	4.58%
2014 Q2	-5.00 CHF	0.0%
2014 Q4	-4.72 CHF	0.0%
2013 Q4	-5.24 CHF	0.0%
2013 FY	- CHF	25.12%
2013 Q1	-3.75 CHF	-5.04%
2013 Q2	-3.75 CHF	0.0%
2013 Q3	-5.24 CHF	-39.73%
2012 Q4	-3.57 CHF	0.0%
2012 Q3	-3.57 CHF	0.0%
2012 FY	- CHF	0.0%

Peer Eps Comparison of Evolva Holding SA

Name	Eps	Eps Difference
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-116900.0%
CSL Limited	2.73 USD	614.286%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	72.351%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-27162.136%
Evofem Biosciences, Inc.	10.35 USD	235.652%
Santhera Pharmaceuticals Holding AG	5.95 USD	335.966%
Propanc Biopharma, Inc.	-0.02 USD	-59140.506%
Mesoblast Limited	-0.09 USD	-15657.576%
Marizyme, Inc.	-1.44 USD	-875.0%
Genus plc	0.12 USD	11800.0%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	-502.575%
CNBX Pharmaceuticals Inc.	-0.42 USD	-3242.857%
Nymox Pharmaceutical Corporation	-0.10 USD	-14449.223%
ContraFect Corporation	-124.97 USD	88.765%
PsyBio Therapeutics Corp.	-0.04 USD	-33328.571%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
IMV Inc.	-4.37 USD	-221.281%
AXIM Biotechnologies, Inc.	-0.04 USD	-39561.017%
MultiCell Technologies, Inc.	-0.00 USD	-14039900.0%
Accustem Sciences Inc.	-0.34 USD	-4029.412%
RVL Pharmaceuticals plc	-0.58 USD	-2320.69%
EV Biologics, Inc.	-0.12 USD	-11600.0%
Q BioMed Inc.	-0.08 USD	-17876.953%
Emmaus Life Sciences, Inc.	-0.07 USD	-19871.55%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-4154.545%
Biomind Labs Inc.	-0.02 USD	-86566.667%
Oncotelic Therapeutics, Inc.	-0.02 USD	-70452.764%
Skye Bioscience, Inc.	-5.37 USD	-161.453%
SQZ Biotechnologies Company	-2.76 USD	-408.696%
THC Farmaceuticals, Inc.	-0.00 USD	-1754900.0%
Arch Therapeutics, Inc.	-2.27 USD	-518.502%
Intellipharmaceutics International Inc.	-0.09 USD	-15964.073%
Acro Biomedical Co., Ltd.	-0.26 USD	-5300.0%
Neon Bloom, Inc.	-0.00 USD	-935900.0%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Pharming Group N.V.	-0.02 USD	-87104.969%
Therapeutic Solutions International, Inc.	-0.00 USD	-2005614.286%
Curative Biotechnology, Inc.	-0.01 USD	-159445.455%
GB Sciences, Inc.	-0.00 USD	-342339.024%
Alpha Cognition Inc.	-0.15 USD	-9260.0%
argenx SE	-5.16 USD	-172.093%
HST Global, Inc.	-0.03 USD	-50222.581%
Halberd Corporation	-0.00 USD	-14039900.0%
Enzolytics Inc.	-0.00 USD	-2005614.286%
Resverlogix Corp.	-0.01 USD	-98773.239%
Arno Therapeutics, Inc.	- USD	Infinity%
Nuo Therapeutics, Inc.	-0.08 USD	-18520.69%
MetaStat, Inc.	- USD	Infinity%
Northwest Biotherapeutics, Inc.	-0.06 USD	-24317.391%
American Oriental Bioengineering, Inc.	-781.24 USD	98.203%
Enzon Pharmaceuticals, Inc.	0.00 USD	1080100.0%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-189629.73%
Endonovo Therapeutics, Inc.	0.03 USD	56036.255%
GlobeStar Therapeutics Corporation	-0.00 USD	-584900.0%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-39227.731%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	-70100.0%
AVAX Technologies, Inc.	-0.05 USD	-25948.237%
ONE Bio Corp.	1.43 USD	1081.818%
Zenith Capital Corp.	-0.07 USD	-19985.837%
Genscript Biotech Corporation	-0.05 USD	-30825.11%
Ember Therapeutics, Inc.	-0.01 USD	-222757.143%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	-272.414%
WPD Pharmaceuticals Inc.	-0.00 USD	-2807900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-15277.875%
Wesana Health Holdings Inc.	-0.05 USD	-27923.952%
Agentix Corp.	-0.04 USD	-40014.286%
Adynxx, Inc.	- USD	Infinity%
Kadimastem Ltd	-0.78 USD	-1700.0%
Helix BioMedix, Inc.	-4.70 USD	-198.723%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Capstone Therapeutics Corp.	-36.39 USD	61.418%
BioStem Technologies, Inc.	-0.62 USD	-2164.516%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-117883.193%
Burzynski Research Institute, Inc.	-0.01 USD	-137547.059%
LadRx Corporation	0.68 USD	2164.706%
Cell Source, Inc.	-0.17 USD	-8158.824%
ProtoKinetix, Incorporated	-0.01 USD	-140300.0%
Regen BioPharma, Inc.	0.29 USD	4941.379%
Regen BioPharma, Inc.	0.26 USD	5500.0%
NovAccess Global Inc.	-0.23 USD	-6004.348%
Affymax, Inc.	-0.39 USD	-3500.0%
Itoco Inc.	-0.01 USD	-184636.842%
Rasna Therapeutics, Inc.	-0.01 USD	-140300.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-561500.0%
CytoDyn Inc.	-0.05 USD	-26440.643%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-2807900.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-63143.243%
Qrons Inc.	-0.06 USD	-23982.333%
Alseres Pharmaceuticals, Inc.	-153.67 USD	90.864%
SYBLEU INC	-0.02 USD	-80128.571%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	-0.01 USD	-104676.119%
Rebus Holdings, Inc.	-0.03 USD	-43638.318%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-98773.239%
Mobile Lads Corp.	-0.01 USD	-250614.286%
International Stem Cell Corporation	-0.02 USD	-85509.756%
Bioxytran, Inc.	-0.03 USD	-43912.539%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-14039900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	-75.72%
Adhera Therapeutics, Inc.	-1.18 USD	-1089.831%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-41194.118%
Innovation Pharmaceuticals Inc.	-0.01 USD	-222757.143%
Neutra Corp.	-0.00 USD	-14039900.0%
Windtree Therapeutics, Inc.	-94.23 USD	85.1%
PureTech Health plc	-2.38 USD	-489.916%
Coeptis Therapeutics, Inc.	-0.83 USD	-1591.566%
IXICO plc	-0.02 USD	-57440.984%
IntelGenx Technologies Corp.	-0.06 USD	-24618.31%
Gelesis Holdings, Inc.	-1.35 USD	-940.0%
CSL Limited	5.47 USD	356.673%
Cellectis S.A.	-1.77 USD	-693.22%

Global Stocks Search

Evolva Holding SA (ELVAF)

Eps Summary of Evolva Holding SA

Annual Eps Chart of Evolva Holding SA (2023 - 2012)

Historical Annual Eps of Evolva Holding SA (2023 - 2012)

Peer Eps Comparison of Evolva Holding SA